Wordt geladen...
Development of Liposomal Ciprofloxacin to Treat Lung Infections
Except for management of Pseudomonas aeruginosa (PA) in cystic fibrosis, there are no approved inhaled antibiotic treatments for any other diseases or for infections from other pathogenic microorganisms such as tuberculosis, non-tuberculous mycobacteria, fungal infections or potential inhaled biowar...
Bewaard in:
| Gepubliceerd in: | Pharmaceutics |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4810082/ https://ncbi.nlm.nih.gov/pubmed/26938551 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics8010006 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|